Summary
Researchers have discovered that morin, a bioflavonoid extracted from traditional plants, can reduce neuroinflammation associated with the inflammasome in cases of drug-resistant epilepsy. The study, conducted by Khedpande and Barve, reveals that morin acts by inhibiting the activation of the inflammasome, a protein complex that plays a crucial role in the brain's inflammatory response. Neurogenic inflammation is an important factor in epilepsy, and reducing this inflammation may improve response to treatment. The results suggest that morin could be a promising alternative for patients who do not respond to conventional treatments, although further research is needed to confirm these findings in humans.
Key points
- Morin inhibits inflammasome activation, reducing neuroinflammation.
- Neuroinflammation is associated with drug resistance in epilepsy.
- The study suggests that morin may be a therapeutic alternative in resistant epilepsy.
✦ For you
If you or someone you know faces difficulties with epilepsy, consider observing how diet and the use of medicinal plants can impact brain health. Morin, present in some plants, may be an option to explore. Always consult a qualified healthcare professional before making significant changes to your health routine.
For practitionersExpand
Consider including morin in protocols for patients with drug-resistant epilepsy. Evaluate the possibility of using plants that contain this bioflavonoid, always taking into account patient individuality and interaction with other treatments. Monitoring effects and clinical response is essential.